Mina S. Sedrak, M.D., M.S.

  • Assistant Professor, Department of Medical Oncology & Therapeutics Research
  • Breast Cancer Oncologist

Mina S. Sedrak, M.D., M.S.

Clinical Specialties
  • Medical Oncology
Areas of Expertise
  • Breast Oncology
  • Geriatric Oncology
Research Focus
  • Breast Cancer and Aging Research
  • Clinical and Biological Predictors of Chemotherapy Toxicity in Older Women with Early-stage, High-risk Breast Cancer
  • Therapeutic Clinical Trials for Older and Frail Patients with Breast Cancer
  • Barriers to Inclusion of Older Adults in Breast Cancer Clinical Trials
  • Social Media and Digital Health
Other Languages Spoken
  • Arabic
Mina S. Sedrak, M.D., M.S., is an assistant professor in the Department of Medical Oncology Therapeutics Research.
Dr. Sedrak is a clinically trained medical oncologist specializing in the care of older adults with breast cancer. The mission of his research program is to improve the health and well-being of older patients with breast cancer. His research interests and ongoing projects include identifying clinical and biological factors that predict the risk of chemotherapy toxicity in older women with early-stage breast cancer, investigating alternate treatment regimen for frail older patients, and improving cancer clinical trial participation of older adults. His training and experience includes analysis of large secondary databases, survey development and qualitative methods, and design of therapeutic clinical trials for older and/or frail adults with cancer, capturing endpoints that are pertinent to this population such as preservation of function, cognition and independence.
Dr. Sedrak is the recipient of several intramural and extramural grants, including an NIH K12 career development award, that support his work at the interface of breast cancer and aging. He serves as co-chair of the Junior Faculty Advisory Board of the “Cancer and Aging Research Infrastructure Grant” (R21/R33 AG059206), co-chair of the Junior Cancer and Aging Research Group, and co-chair of the Breast Cancer Working Group in the Alliance Cancer in the Older Adult Committee. Additionally, Dr. Sedrak serves on the National Cancer Institute’s Diversifying Accrual Working Group, bringing expertise as a geriatric oncology researcher and informing methods of improving the accrual of older adults with cancer. He is also an appointed member of the ASCO Scientific Program Committee and serves on the Cancer.Net Editorial Board’s geriatric oncology advisory panel.
Dr. Sedrak earned his undergraduate degree in biological sciences from University of Chicago. He received his medical doctorate from Rush Medical College, where he was inducted into the Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in hematology/oncology at the University of Pennsylvania, where he also received a Master of Science in Health Policy Research.
  • 2016 – Present, Assistant Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
  • Breast Cancer
  • Cancer Control & Population Sciences


  • 2015, MS, Health Policy Research, University of Pennsylvania, Philadelphia, PA
  • 2010, MD, Medicine, Rush Medical College, Chicago, IL
  • 2006, BA, Biological Sciences, University of Chicago, Chicago, IL


  • 2015 - 2016, Measey Medical Education Fellow in Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
  • 2014 - 2016, Clinical Fellow, Center for Healthcare Improvement and Patient Safety, University of Pennsylvania, Philadelphia, PA
  • 2013 -2016, Research Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA
  • 2013 - 2016, Fellow, Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA


  • 2011 - 2013, Resident, Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA


  • 2010 - 2011, Intern, Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
  • 2016, American Board of Internal Medicine Certified, Medical Oncology
  • 2013, American Board of Internal Medicine Certified, Internal Medicine
  • Sedrak MS, Dizon DS, Anderson PF, Fisch MJ, Graham DL, Katz MS, Kesselheim JC, Miller RS, Thompson MA, Utengen A, Attai DJ. The Emerging Role of Professional Social Media Use in Oncology. Future Oncology. 2017: Published online June 7. PMID: 28589770.
  • Sedrak MS, Myers JS, Small DS, Nachamkin I, Ziemba JB, Murray D, Kurtzman GW, Zhu J, Wang W, Mincarelli D, Danoski D, Wells BP, Berns JS, Brennan PJ, Hanson CW, Dine CJ, Patel MS.  Effect of a Price Transparency Intervention in the Electronic Health Record on Clinician Ordering of Inpatient Laboratory Tests: The PRICE Randomized Clinical Trial. JAMA Internal Medicine. 2017.
  • Sedrak MS, Patel MS, Ziemba JB, Murray D, Kim EJ, Dine CJ, Myers JS. Residents’ Self-report on Why They Order Perceived Unnecessary Inpatient Laboratory Tests. Journal of Hospital Medicine. Aug 2016. [Epub ahead of print]. PMID: 27520384.
  • Attai DJ, Sedrak MS*, Katz MS, Thomspon MA, Anderson PF, Kesselheim JC, Fisch MJ, Graham DL, Utengen A, Johnston C, Miller RS, Dizon DS. Social Media in Cancer Care: Highlights, Challenges and Opportunities. Future Oncology. 12(13):1549-52, Jul 2016. PMID: 27025657. [*Co-first author]
  • Sedrak MS, Cohen RB, Merchant RM, Schapira MM. Cancer Communication in the Social Media Age. JAMA Oncology. 1;2(6):822-3, Jun 2016. PMID: 26940041.
  • Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun-Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR. Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients With Ulcerative Colitis: A Case-Control Study. Clinical Gastroenterology and Hepatology. 11(12): 1601-8, Dec 2013. PMID: 23872237.
  • Barbieri JS, Seshasai R, Shemesh A, Sedrak MS, Hoffman B, Alley EW. Thymic Neuroendocrine Tumor Presenting with the Ectopic ACTH Syndrome. Journal of Thoracic Oncology. 8(6): e57-8, Jun 2013. PMID: 23676563.

Complete list of published work

  • 2017 - Present, Southwest Oncology Group
  • 2017 - Present, Cancer and Aging Research Group
  • 2015 - Present, Alliance of Academic Internal Medicine
  • 2013 - Present, American Society of Clinical Oncology
  • 2013 - Present, American Society of Hematology
  • 2009 - 2013 American College of Physicians
  • 2006 - 2010, American Medical Association, President, Medical Student Section, Rush Medical College Chapter, 2007 - 2008
  • 2017, NIH/NCI Paul Calabresi Career Development Award (K12)
  • 2017, Dr. Charles A. Coltman, Jr., Fellowship Award, SWOG
  • 2017, NIA Butler-Williams Scholar
  • 2017, Waisman Innovation Award, City of Hope
  • 2016, Conquer Cancer Foundation of American Society of Clinical Oncology Merit Award
  • 2015, Quality and Safety Award, Honorable Mention, University of Pennsylvania Health Systems
  • 2015, First Place Prize, Award of Excellence for Research Poster, Association of Program Directors in Internal Medicine
  • 2015, Excellence in Quality and Safety Leadership, University of Pennsylvania Health System
  • 2014, Penn Pearls Teaching Award for Excellence in Clinical Teaching, Perelman School of Medicine University of Pennsylvania
  • 2013, Maurice F. Attie Senior Resident Teaching Award, Department of Medicine, Hospital of the University of Pennsylvania
  • 2010, Leonard Tow Humanism in Medicine Award, The Arnold P. Gold Foundation
  • 2010, William H. Harrison, Ph.D. Award in Leadership, Rush Medical College
  • 2010, Ortho Sprague/Whitney Addington Award in Community Service, Rush Medical College
  • 2010, James A. Schoenberger, MD Prize in Preventative Medicine, Rush Medical College
  • 2009, Gold Humanism Honor Society, Rush Medical College
  • 2009, Alpha Omega Alpha Honor Medical Society, Rush Medical College
  • 2009, Robert Ryan, MD Excellence Scholarship for outstanding clinical performance, Rush Medical College
  • 2008, Leonidas H. Berry, MD Excellence Scholarship for preclinical performance, Rush Medical College
Back To Top